Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
The Journal of Investigative Dermatology
|
April 28, 2005
A novel deletion mutation in keratin 5 causing the removal of 5 amino acids and elevated mutant mRNA levels in Dowling-Meara epidermolysis bullosa simplex
M W Kemp, S Klingberg, L Lloyd, et al.
Clinical and Experimental Dermatology
|
August 21, 2008
Clinical heterogeneity in recessive epidermolysis bullosa due to mutations in the keratin 14 gene, KRT14
E Yiasemides, N Trisnowati, J Su, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
January 8, 2022
Cortical thickness across the cingulate gyrus in schizophrenia and its association to illness duration and memory performance
J-W Thielen, B W Müller, D-I Chang, et al.
Acta Psychiatrica Scandinavica
|
September 11, 2012
Should early improvement be re-defined to better predict the maintenance of response in first-episode schizophrenia patients?
R Schennach, M Riesbeck, A Mayr, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
May 1, 2012
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder
R Schennach, S Meyer, F Seemüller, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
December 27, 2014
What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?
R Schennach, M Riedel, M Obermeier, et al.
Acta Psychiatrica Scandinavica
|
October 30, 2010
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale
R Schennach-Wolff, M Obermeier, F Seemüller, et al.
Acta Psychiatrica Scandinavica
|
November 3, 2009
Outcome of suicidal patients with schizophrenia: results from a naturalistic study
R Schennach-Wolff, M Jäger, F Seemüller, et al.
Pharmacopsychiatry
|
October 8, 2010
A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials
R Schennach-Wolff, H-J Möller, M Jäger, et al.
Behavioural Brain Research
|
December 21, 2013
Investigation of decision-making under uncertainty in healthy subjects: a multi-centric fMRI study
A Krug, M Cabanis, M Pyka, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
The Journal of Investigative Dermatology
|
April 28, 2005
A novel deletion mutation in keratin 5 causing the removal of 5 amino acids and elevated mutant mRNA levels in Dowling-Meara epidermolysis bullosa simplex
M W Kemp, S Klingberg, L Lloyd, et al.
Clinical and Experimental Dermatology
|
August 21, 2008
Clinical heterogeneity in recessive epidermolysis bullosa due to mutations in the keratin 14 gene, KRT14
E Yiasemides, N Trisnowati, J Su, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
January 8, 2022
Cortical thickness across the cingulate gyrus in schizophrenia and its association to illness duration and memory performance
J-W Thielen, B W Müller, D-I Chang, et al.
Acta Psychiatrica Scandinavica
|
September 11, 2012
Should early improvement be re-defined to better predict the maintenance of response in first-episode schizophrenia patients?
R Schennach, M Riesbeck, A Mayr, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
May 1, 2012
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder
R Schennach, S Meyer, F Seemüller, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
December 27, 2014
What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?
R Schennach, M Riedel, M Obermeier, et al.
Acta Psychiatrica Scandinavica
|
October 30, 2010
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale
R Schennach-Wolff, M Obermeier, F Seemüller, et al.
Acta Psychiatrica Scandinavica
|
November 3, 2009
Outcome of suicidal patients with schizophrenia: results from a naturalistic study
R Schennach-Wolff, M Jäger, F Seemüller, et al.
Pharmacopsychiatry
|
October 8, 2010
A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials
R Schennach-Wolff, H-J Möller, M Jäger, et al.
Behavioural Brain Research
|
December 21, 2013
Investigation of decision-making under uncertainty in healthy subjects: a multi-centric fMRI study
A Krug, M Cabanis, M Pyka, et al.
Page
of 5